PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Ospemifene - Vaginal atrophy

PAD Profile : Ospemifene - Vaginal atrophy

Keywords :
menopause, menopausal symptoms, vaginal oestrogen, oestrogen deficiency, vaginal dryness, selective oestrogen receptor modulators
Brand Names Include :
Senshio

Traffic Light Status

Status 1 of 1.

Status :
Blue
Important
Formulations :
  • Tablets
Important Information :
Initiation in primary care following specialist recommendation. Reserve for severe dryness or when other treatments are ineffective / contraindicated.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

No indications returned.

Additional Documents

Type
Document
Review Date

Committee Recommendations

Date
Committee Name
Narrative
03 July 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands APC has agreed a traffic light status and place in therapy for the treatments of menopausal disorders in line with the CKS recommenations:

Menopause | Health topics A to Z | CKS | NICE

Associated BNF Codes

06. Endocrine System
06.04.01. Female sex hormones and their modulators
07. Obstetrics, Gynaecology and Urinary-Tract Disorders
07.02.01. Preparations for vaginal and vulval changes
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More